Health Care • Medical/Dental Instruments
$54.49 ▼ -4.56
(-7.72%)
MKT CAP: $5.13B • VOL: 1.65M
52W L $20 52W H $61
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$46
MEDIAN
$61
MEAN
$62
HIGH
$74
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE HTFL TAPE
HTFL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $65.93 | $62.66 | 2025-02-14 | $49.59 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $68.66 | $64.30 | 2025-02-06 | $51.22 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $62.12 | $59.94 | 2025-01-29 | $52.31 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $55.58 | — | 2025-01-17 | $53.40 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $47.95 | $51.77 | 2025-01-09 | $48.50 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $64.84 | $56.67 | 2024-12-18 | $47.41 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $52.86 | $55.03 | 2024-12-04 | $50.68 | -4.3% | 48% | C |